Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  Loncar, Robert ^a   Kalina, Uwe ^b   Stoldt, Volker ^a   Thomas, Volker ^a   Scharf, Rüdiger E ^a   Vodovnik, Aleksandar ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b ZLB Behring   (Germany)

^c CALDERDALE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRINOGEN; FLUORESCENT DYE;

ADULT; ANTICOAGULATION; ARTICLE; CELL LABELING; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; PERFUSION; PROTEIN IMMOBILIZATION; SHEAR RATE; SIMULATION; THROMBOCYTE ADHESION;

EID: 33750604082     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-19     Document Type: Article

References (26)

1. Stassen JM, Arnout J, Deckmyn H: The hemostatic system. Curr Med Chem 2004, 11:2245-2260.
2. Rosenberg RD: Biochemistry of heparin antithrombin interaction and the physiological role of this natural anticoagulation mechanism. Am J Med 1989, 87:2S-9S.
3. Kremser L, Bruckner A, Heger A, Grunert T, Buchacher A, Josic D, Allmaier G, Rizzi A: Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods. Electrophoresis 2003, 24:4282-4290.
4. Larsson H, Akerud P. Nordling K, Raub-Segall E, Claesson-Welsh L, Bjork I: A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity. J Biol Chem 2001, 276:11996-2002.
5. Lindahl U, Backstrom G, Thunberg L: The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J Biol Chem 1983, 258:9826-9830.
6. Yamauchi T, Umeda F, Inoguchi T, Nawata H: Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989, 163:1404-1411.
7. Uchiba M, Okajima, Murakami K. Okabe H, Takatsuku K: Attenuation of andotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol Lung Cell Mol Physiol 1996, 270:L921-C930.
8. Harada. N, Okajima K, Kushimoto S, Isobe H, Tanaka K: Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 1999, 93:157-64.
9. O'Reilly MS, Pirie-Sheperd S, Lane WS, Folkman J: Antianglogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999, 285:1926-1928.
10. Yamashiro K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Miyamoto K, Honda Y, Tanihara H, Ogura Y: Inhibitory effects of antithrombin III against leukocyte rolling and Infiltration during endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2001, 42:1553-1560.
11. Warren BL, Eid A. Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM: KyberSept Trial Study Group. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286:1869-1878.
12. Salvatierra A, Guerrero R, Rodriguez M, Alvarez A, Soriano F, Lopez-Pedrera R, Ramirez R, Carracedo J, Lopez-Rubio F, Lopez-Pujol J, Velasco F: Antithrombin III prevents early pulmonary dysfunction after lung Transplantation in the dog. Circulation 2001, 104:2975-2980.
13. Inthorn D, Hoffmann JN, Hartl WH, Mühlbayer D, Jochum M: Effect of antithrombin III supplementation on inflammatory immune response in patients with severe sepsis. Shock 1998, 10:90-96.
14. Mizutani A, Okajima K, Uchiba M, Isobe H, Harada N, Mizutani S, Noguchi T: Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 2003, 101:3029-36.
15. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD: Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase patway. Am J Physiol Cell Physiol 2000, 279:C98-C107.
16. Nishijima K, Kiryu J, Tsujikawa A. Honjo M, Nonaka A, Yamashiro K, Kamizuru H, leki Y, Tanihara H, Honda Y, Ogura Y: Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2003, 44:332-341.
17. Savage B, Saldivar E, Ruggeri ZM: Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996, 84:289-297.
18. van Kooten TG, Schakenraad JM, Van der Mei HC, Busscher HJ: Development and use of a parallel-plate flow chamber for studying cellular adhesion to solid surfaces. J Biomed Meter Res 1992, 26:725-38.
19. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and ist role in atherosclerosis. JAMA 1999, 282:2035-2042.
20. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998, 101:479-486.
21. Andersen O, Flengsrud R, Norberg K, Salte R: Antithrombin has only three carbohydrate side chains, and shows functional similarities to human beta-antithrombin. Eur J Biochem 2000, 267:1651-1657.
22. Kondo S, Kisiel W: Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa. Thromb Res 1987, 46:325-335.
23. Zaidi TN, McIntire LV, Farrell DH, Thiagarajan P: Adhesion of platelets to surface-bound fibrinogen under flow. Blood 1996, 88:2967-2972.
24. Ruggeri ZM: Platelets in atherothrombosis. Nature Medicine 2002, 28:1227-1234.
25. Larsson H, Sjoblom T, Dixelius J, Ostman A, Ylinenjarvi K, Bjork I, Claesson-Welsh L: Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res 2000, 60:6723-6729.
26. Yamashiro K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Miyamoto K. Honda Y, Tanihara H, Ogura Y: Inhibitory effects of antithrombin III against leukocyte rolling and Infiltration during endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2001, 42:1553-1560.